GRK2 Protein — G Protein-Coupled Receptor Kinase 2

GRK2 Protein — G Protein-Coupled Receptor Kinase 2

Introduction

Grk2 Protein — G Protein Coupled Receptor Kinase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

GRK2 Protein — G Protein-Coupled Receptor Kinase 2

Introduction

Grk2 Protein — G Protein Coupled Receptor Kinase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@grk2018]
<table> [@betaarrestin2019]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">G Protein-Coupled Receptor Kinase 2</th></tr> [@grk2020]
<tr><td><strong>Protein Name</strong></td><td>GRK2 (Beta-adrenergic receptor kinase 1)</td></tr> [@synuclein2017]
<tr><td><strong>Gene</strong></td><td>[GRK2](/genes/grk2)</td></tr> [@grk2021]
<tr><td><strong>UniProt ID</strong></td><td>[P10147](https://www.uniprot.org/uniprot/P10147)</td></tr> [@dopamine2016]
<tr><td><strong>PDB Structure</strong></td><td>1MT5, 3MRK</td></tr> [@grk2019]
<tr><td><strong>Molecular Weight</strong></td><td>80 kDa (756 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, cytoplasm, nucleus</td></td>
<tr><td><strong>Protein Family</strong></td><td>GRK (G protein-coupled receptor kinase) family</td></tr>
<tr><td><strong>Enzyme Classification</strong></td><td>Serine/Threonine protein kinase</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">109 edges</a></td>
</tr>
</table>
</div>

Overview

GRK2 (G protein-coupled Receptor Kinase 2), also known as ADRBK1 (Beta-adrenergic Receptor Kinase 1), is a member of the GRK family of serine/threonine kinases. GRK2 plays a critical role in regulating G protein-coupled receptor (GPCR) signaling through receptor phosphorylation and arrestin recruitment. Beyond GPCR regulation, GRK2 modulates numerous signaling pathways relevant to neurodegeneration, including dopaminergic signaling, inflammation, and cell survival.

Structure

GRK2 contains three distinct functional domains:

N-terminal RGS Domain (1-185 aa)

• Regulator of G protein Signaling domain
• Binds Gα subunits and accelerates GTP hydrolysis
• Mediates protein-protein interactions
• Contains the RH (RGS homology) fold

Kinase Domain (186-532 aa)

• Catalytic serine/threonine kinase domain
• Requires activation by Gβγ subunits
• Phosphorylates serine/threonine residues on GPCR intracellular loops
• Contains the conserved HRD motif in the catalytic loop

C-terminal PH Domain (533-675 aa)

• Pleckstrin Homology domain
• Binds phosphatidylinositol (PI) lipids at the plasma membrane
• Facilitates membrane localization
• Interacts with Gβγ subunits

Normal Function

GPCR Desensitization

GRK2 is best known for its role in GPCR regulation:

Substrate Receptors

GRK2 phosphorylates numerous GPCRs:

• β-adrenergic receptors (β1AR, β2AR)
• Dopamine receptors (D1R, D2R)
• Muscarinic receptors (M2, M3)
• Serotonin receptors (5-HT2R)
• Glutamate receptors (mGluR5)

Non-GPCR Substrates

• P53: Tumor suppressor phosphorylation
• IκBα: [NF-κB](/entities/nf-kb) pathway regulation
• ERK1/2: MAPK pathway modulation
• Akt: PI3K/Akt signaling

Role in Neurodegenerative Diseases

Parkinson's Disease (PD)

GRK2 is critically involved in PD pathogenesis:

• Dopaminergic dysfunction: Elevated GRK2 in the substantia nigra of PD patients
• D2 receptor desensitization: Enhanced GRK2 activity leads to D2R hypofunction
• α-synuclein interaction: GRK2 can phosphorylate α-synuclein at Ser129
• Neuroinflammation: GRK2 regulates microglial activation via CXCR signaling

Alzheimer's Disease (AD)

• APP processing: GRK2 may influence [amyloid precursor protein](/entities/app-protein) processing
• Synaptic dysfunction: Alters AMPA and [NMDA receptor](/entities/nmda-receptor) trafficking
• Cholinergic signaling: Modulates muscarinic [acetylcholine](/entities/acetylcholine) receptor function

Huntington's Disease (HD)

• Dopamine signaling: GRK2 dysregulation affects D1/D2 receptor signaling
• Transcriptional dysregulation: Modulates REST and [huntingtin](/proteins/huntingtin) function

Amyotrophic Lateral Sclerosis (ALS)

• Motor neuron degeneration: Altered GRK2 in spinal cord motor [neurons](/entities/neurons)
• Glutamate excitotoxicity: Modulates metabotropic glutamate receptor signaling

Therapeutic Implications

GRK2 Inhibitors

Several GRK2 inhibitors are under development:

• Paroxetine: FDA-approved antidepressant with GRK2 inhibitory activity
• JPGZ71: Selective GRK2/β-arrestin inhibitor
• Compound 101: GRK2 peptide inhibitor

Treatment Strategies

• Parkinson's disease: GRK2 inhibitors may restore dopaminergic signaling
• Heart failure: GRK2 inhibition improves cardiac function
• Neuroinflammation: Targeting GRK2 in [microglia](/cell-types/microglia-neuroinflammation)

Interactions

| Partner | Interaction Type | Function |
|---------|-----------------|----------|
| [D2 Dopamine Receptor](/proteins/drd2-protein) | Substrate | Receptor phosphorylation |
| Gαq | Interaction | RGS domain binding |
| Gβγ | Interaction | Kinase activation |
| β-arrestin | Partner | Receptor desensitization |
| [α-Synuclein](/proteins/alpha-synuclein) | Substrate | Ser129 phosphorylation |
| IκBα | Substrate | NF-κB regulation |

See Also

• [GRK2 Gene](/genes/grk2)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [G Protein Signaling](/mechanisms/g-protein-coupled-receptor-signaling)
• [Dopamine Receptors](/mechanisms/dopamine-signaling)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Beta-Arrestin Signaling](/mechanisms/arrestin-signaling)

External Links

• [UniProt P10147](https://www.uniprot.org/uniprot/P10147)
• [NCBI Gene: GRK2](https://www.ncbi.nlm.nih.gov/gene/156)
• [PDB: 1MT5](https://www.rcsb.org/structure/1MT5)

Background

The study of Grk2 Protein — G Protein Coupled Receptor Kinase 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References